# Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

> **NCT00860262** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 858 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** amlodipine
- **DRUG:** telmisartan
- **DRUG:** telmisartan and amlodipine

## Key facts

- **NCT ID:** NCT00860262
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 858 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00860262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00860262, "Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00860262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*